Transense Technologies PLC
07 December 2007
Transense Technologies plc
('Transense' or the 'Company')
Admission of shares
Pursuant to the subscription agreement between the Company and Peter Lobbenberg
announced 21 November 2007, Transense announces that 1,043,500 new ordinary
shares ('New Ordinary Shares') of 10p each have been issued and allotted to Hero
Nominees Ltd, which is a nominee company for certain persons connected with
Peter Lobbenberg.
Application has been made to the London Stock Exchange for the New Ordinary
Shares, which will rank pari passu with the existing shares in issue, to be
admitted to trading on AIM, and admission is expected to become effective on 10
December 2007.
Peter Lobbenberg has notified the Company that following the issue of the New
Ordinary Shares he and his connected persons had an interest in 3,669,436
ordinary shares, representing 6.34% of the issued share capital of the Company.
Following the admission the number of Ordinary Shares in issue will be
57,911,666.
- Ends -
Enquiries:
Transense Technologies plc 01869 238 380
Jim Perry / Graham Eves
Noble & Company Limited 020 7763 2200
John Llewellyn-Lloyd / Graeme Bayley
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.